{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:57:16Z","timestamp":1768042636242,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"DOI":"10.7759\/cureus.101204","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T06:59:52Z","timestamp":1768028392000},"source":"Crossref","is-referenced-by-count":0,"title":["Survival Outcomes and Clinicopathologic Prognostic Factors in Gastric Cancer: A Small Single-Center Retrospective Cohort From Eastern T\u00fcrkiye"],"prefix":"10.7759","author":[{"given":"Sezer","family":"G\u00f6k\u00e7en","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut Baran","family":"Yerlikaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adem","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harun","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tutku","family":"T\u00fcfek\u00e7i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakup Ozan","family":"Verendag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2025.0022","article-title":"Gastric cancer, version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Ajani JA","year":"2025","unstructured":"Ajani JA, D'Amico TA, Bentrem DJ, et al.. Gastric cancer, version 2.2025, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2025, 23:169-91. 10.6004\/jnccn.2025.0022","journal-title":"J Natl Compr Canc Netw"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma","volume":"64","author":"Lauren P","year":"1965","unstructured":"Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand. 1965, 64:31-49. 10.1111\/apm.1965.64.1.31","journal-title":"Acta Pathol Microbiol Scand"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","article-title":"AJCC Cancer Staging Manual. 8th ed","year":"2017","unstructured":"AJCC Cancer Staging Manual. 8th ed. Amin MB, Edge SB, Greene FL (ed). Springer, New York; 2017. 10.1007\/978-3-319-40618-3"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham D","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al.. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006, 355:11-20. 10.1056\/NEJMoa055531","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32557-1","article-title":"Perioperative chemotherapy with FLOT versus ECF\/ECX for resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a multicentre, randomised phase 2\/3 trial","volume":"393","author":"Al-Batran SE","year":"2019","unstructured":"Al-Batran SE, Homann N, Pauligk C, et al.. Perioperative chemotherapy with FLOT versus ECF\/ECX for resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a multicentre, randomised phase 2\/3 trial. Lancet. 2019, 393:1948-57. 10.1016\/S0140-6736(18)32557-1","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.14.621","article-title":"Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database","volume":"23","author":"Smith DD","year":"2005","unstructured":"Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005, 23:7114-24. 10.1200\/JCO.2005.14.621","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-012-0169-y","article-title":"How many lymph nodes should be assessed in patients with gastric cancer? A systematic review","volume":"15 Suppl 1","author":"Seevaratnam R","year":"2012","unstructured":"Seevaratnam R, Bocicariu A, Cardoso R, et al.. How many lymph nodes should be assessed in patients with gastric cancer? A systematic review. Gastric Cancer. 2012, 15 Suppl 1:S70-88. 10.1007\/s10120-012-0169-y","journal-title":"Gastric Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000250423.43436.e1","article-title":"The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients","volume":"245","author":"Marchet A","year":"2007","unstructured":"Marchet A, Mocellin S, Ambrosi A, et al.. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg. 2007, 245:543-52. 10.1097\/01.sla.0000250423.43436.e1","journal-title":"Ann Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-200","article-title":"Clinical implications of metastatic lymph node ratio in gastric cancer","volume":"7","author":"Liu C","year":"2007","unstructured":"Liu C, Lu P, Lu Y, Xu H, Wang S, Chen J. Clinical implications of metastatic lymph node ratio in gastric cancer. BMC Cancer. 2007, 7:200. 10.1186\/1471-2407-7-200","journal-title":"BMC Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029798","article-title":"Meta-analysis of the relationship between lymphovascular invasion and prognosis of patients with stage I gastric cancer","volume":"101","author":"Li D","year":"2022","unstructured":"Li D, Li W, Pang Y, Liu S, Xu L, Xu X. Meta-analysis of the relationship between lymphovascular invasion and prognosis of patients with stage I gastric cancer. Medicine (Baltimore). 2022, 101:e29798. 10.1097\/MD.0000000000029798","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/10732748211043665","article-title":"Positive resection margin as a prognostic factor for gastric cancer: a systematic review and meta-analysis","volume":"28","author":"Jiang Z","year":"2021","unstructured":"Jiang Z, Liu C, Cai Z, et al.. Positive resection margin as a prognostic factor for gastric cancer: a systematic review and meta-analysis. Cancer Control. 2021, 28:10732748211043665. 10.1177\/10732748211043665","journal-title":"Cancer Control"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450708-survival-outcomes-and-clinicopathologic-prognostic-factors-in-gastric-cancer-a-small-single-center-retrospective-cohort-from-eastern-trkiye","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T06:59:53Z","timestamp":1768028393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450708-survival-outcomes-and-clinicopathologic-prognostic-factors-in-gastric-cancer-a-small-single-center-retrospective-cohort-from-eastern-trkiye"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.101204","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}